Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Zhang M, Qin Y, Wan J, Tian Z, et al. Dose-dense neoadjuvant bi-weekly nab-paclitaxel followed by epirubicin-cyclophosphamide versus bi-weekly docetaxel followed by epirubicin-cyclophosphamide in patients with HR+/HER2- early breast cancer: a multicentre, randomised, phase III trial. Breast Cancer Res Treat 2026;220:32.
PMID: 43003936


Privacy Policy